Literature DB >> 30714732

In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application.

Michael L Drummond1, Christopher I Williams1.   

Abstract

In this work, four methods are described and validated for generating in silico ensembles of PROTAC-mediated ternary complexes. Filters based on characteristics of the proposed ternary complexes are developed to identify those that resemble known crystal structures. We then show how to use these modeling techniques a priori to discriminate the PROTAC-mediated degradation behavior of a mutant protein vs its wild type, of three closely related targets, and among three different PROTAC molecules.

Mesh:

Substances:

Year:  2019        PMID: 30714732     DOI: 10.1021/acs.jcim.8b00872

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  21 in total

Review 1.  PROTACs: great opportunities for academia and industry.

Authors:  Xiuyun Sun; Hongying Gao; Yiqing Yang; Ming He; Yue Wu; Yugang Song; Yan Tong; Yu Rao
Journal:  Signal Transduct Target Ther       Date:  2019-12-24

Review 2.  Emerging modes-of-action in drug discovery.

Authors:  Eric Valeur; Frank Narjes; Christian Ottmann; Alleyn T Plowright
Journal:  Medchemcomm       Date:  2019-06-25       Impact factor: 3.597

3.  Identification of ligand linkage vectors for the development of p300/CBP degraders.

Authors:  Duncan K Brownsey; Ben C Rowley; Evgueni Gorobets; Koichiro Mihara; Ranjan Maity; James W Papatzimas; Benjamin S Gelfand; Morley D Hollenberg; Nizar J Bahlis; Darren J Derksen
Journal:  RSC Med Chem       Date:  2022-04-14

4.  The Growing Importance of Chirality in 3D Chemical Space Exploration and Modern Drug Discovery Approaches for Hit-ID: Topical Innovations.

Authors:  Ilaria Proietti Silvestri; Paul J J Colbon
Journal:  ACS Med Chem Lett       Date:  2021-07-16       Impact factor: 4.632

Review 5.  Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges.

Authors:  Chao Wang; Yujing Zhang; Tingting Zhang; Lingyu Shi; Zhongmin Geng; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 6.  PROTACs for BRDs proteins in cancer therapy: a review.

Authors:  Chao Wang; Yujing Zhang; Shanbo Yang; Wujun Chen; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 7.  Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents.

Authors:  Chao Wang; Yujing Zhang; Lingyu Shi; Shanbo Yang; Jing Chang; Yingjie Zhong; Qian Li; Dongming Xing
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

8.  Covalent PROTACs: the best of both worlds?

Authors:  Neil P Grimster
Journal:  RSC Med Chem       Date:  2021-07-15

9.  Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta.

Authors:  Nan Bai; Sven A Miller; Grigorii V Andrianov; Max Yates; Palani Kirubakaran; John Karanicolas
Journal:  J Chem Inf Model       Date:  2021-02-24       Impact factor: 4.956

10.  Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes.

Authors:  James Schiemer; Reto Horst; Yilin Meng; Justin I Montgomery; Yingrong Xu; Xidong Feng; Kris Borzilleri; Daniel P Uccello; Carolyn Leverett; Stephen Brown; Ye Che; Matthew F Brown; Matthew M Hayward; Adam M Gilbert; Mark C Noe; Matthew F Calabrese
Journal:  Nat Chem Biol       Date:  2020-11-16       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.